Keywords: novartis, rad001, gets, priority, review, swiss, drug

Novartis' RAD001 gets US priority review

Article | 15 September 2008

Print This

Swiss drug major Novartis says that RAD001 (everolimus) has been granted priority review by the US Food and Drug Administration. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in